Institutional Ownership
Inhibrx Biosciences Inc
CUSIP 45720N103COMINBXQ1 2026
Institutional Holders
128
13F filers
Shares Held
12.05M
Aggregate institutional
Institutional Value
$808.72M
Q1 2026
Net New Holders
-7
17 new · 24 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions17
Increased55
Decreased34
Sold out24
Institutional Holders
128 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Perceptive Advisors LLC | 1.44M | $96.99M | −10.0K | Reduced |
| 2 | Viking Global Investors LP | 1.44M | $96.66M | 0 | Held |
| 3 | Morgan Stanley | 1.26M | $84.92M | +95.3K | Added |
| 4 | Sanofi | 1.16M | $77.85M | 0 | Held |
| 5 | Hightower Advisors, LLC | 870.2K | $58.50M | −307 | Reduced |
| 6 | Blackrock, Inc. | 798.9K | $53.71M | +21.5K | Added |
| 7 | State Street Corp | 550.8K | $37.03M | +175.9K | Added |
| 8 | Sofinnova Investments, Inc. | 406.0K | $27.30M | −48.6K | Reduced |
| 9 | Capital Research Global Investors | 392.8K | $26.41M | −28.7K | Reduced |
| 10 | Woodline Partners LP | 384.4K | $25.85M | +245.0K | Added |
118 more institutional holders on Premium
See every fund holding Inhibrx Biosciences Inc, with full quarter-over-quarter share changes.
Unlock all holders